Gotowe bibliografie tematyczne / Obstructive sleep apnoea

Gotowa bibliografia na temat „Obstructive sleep apnoea”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Obstructive sleep apnoea”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Obstructive sleep apnoea"

1

Phua, C. Q., W. X. Yeo, C. Su i P. K. H. Mok. "Multi-level obstruction in obstructive sleep apnoea: prevalence, severity and predictive factors". Journal of Laryngology & Otology 131, nr 11 (5.09.2017): 982–86. http://dx.doi.org/10.1017/s0022215117001906.

Pełny tekst źródła
Streszczenie:
AbstractObjectives:To characterise multi-level obstruction in terms of prevalence, obstructive sleep apnoea severity and predictive factors, and to collect epidemiological data on upper airway morphology in obstructive sleep apnoea patients.Methods:Retrospective review of 250 obstructive sleep apnoea patients.Results:On clinical examination, 171 patients (68.4 per cent) had multi-level obstruction, 49 (19.6 per cent) had single-level obstruction and 30 (12 per cent) showed no obstruction. Within each category of obstructive sleep apnoea severity, multi-level obstruction was more prevalent. Multi-level obstruction was associated with severe obstructive sleep apnoea (more than 30 events per hour) (p = 0.001). Obstructive sleep apnoea severity increased with the number of obstruction sites (correlation coefficient = 0.303, p < 0.001). Multi-level obstruction was more likely in younger (p = 0.042), male (p = 0.045) patients, with high body mass index (more than 30 kg/m2) (p < 0.001). Palatal (p = 0.004), tongue (p = 0.026) and lateral pharyngeal wall obstructions (p = 0.006) were associated with severe obstructive sleep apnoea.Conclusion:Multi-level obstruction is more prevalent in obstructive sleep apnoea and is associated with increased severity. Obstruction at certain anatomical levels contributes more towards obstructive sleep apnoea severity.
Style APA, Harvard, Vancouver, ISO itp.
2

Polo, O., L. Brissaud, B. Sales, A. Besset i M. Billiard. "The validity of the static charge sensitive bed in detecting obstructive sleep apnoeas". European Respiratory Journal 1, nr 4 (1.04.1988): 330–36. http://dx.doi.org/10.1183/09031936.93.01040330.

Pełny tekst źródła
Streszczenie:
The demand for polysomnographic recordings associated with respiratory control exceeds the capacity of the few existing sleep disorder centres and therefore a simple and inexpensive method is needed for screening and diagnosing sleep-related breathing disorders. The static charge sensitive bed (SCSB) permits long-term recordings of body movements, respiratory movements and the ballistocardiogram (BCG) without electrodes or cables being attached to the subject. The aim of the present study was to test the validity of this particular method in detecting obstructive sleep apnoeas without airflow measurements. Simultaneous SCSB and spirometer recordings were compared in fourteen sleep apnoea patients and six controls. The mean sensitivity of the SCSB method to detect the obstructive apnoeas was 0.92-0.98. The specificity to detect 2 min apnoea epochs was 0.61-0.68 in the apnoea group, while in the control group it was 0.99-1.00. According to this study, the SCSB detects the obstructive events without always distinguishing between severe periodic hypopnoeas and obstructive apnoeas. The sensitivity of the SCSB makes it valuable for screening subjects suspected of having obstructive sleep apnoeas. Further studies will concentrate on a more detailed analysis of the various respiratory, BCG and body movement patterns, which may lead to additional information on the severity of the upper airway obstruction.
Style APA, Harvard, Vancouver, ISO itp.
3

Gutierrez, T., A. C. Leong, L. Pang, E. Chevretton, J.-P. Jeannon i R. Simo. "Multinodular thyroid goitre causing obstructive sleep apnoea syndrome". Journal of Laryngology & Otology 126, nr 2 (12.10.2011): 190–95. http://dx.doi.org/10.1017/s0022215111002714.

Pełny tekst źródła
Streszczenie:
AbstractBackground:Obstructive sleep apnoea syndrome has been linked to obesity, nasal obstruction and adenotonsillar hypertrophy, but rarely to large thyroid goitres.Objective:To study the possible association between multinodular retrolaryngo-pharyngeal or retrosternal goitres and obstructive sleep apnoea syndrome.Subjects and methods:Retrospective case series at a tertiary referral centre (2000–2010). Study parameters included body mass index, Epworth sleep score and polysomnographic index.Results:Five patients were diagnosed with obstructive sleep apnoea syndrome and managed with nasal continuous positive airway pressure ventilation. Computed tomography showed a retrolaryngo-pharyngeal or retrosternal goitre with significant tracheal compression, displacement and laryngeal oedema. After total thyroidectomy, obstructive sleep apnoea resolved in all patients.Conclusion:Large, multinodular goitres with retrolaryngo-pharyngeal extension can cause obstructive sleep apnoea syndrome due to laryngeal compression and oedema. In such cases, total thyroidectomy enables resolution of symptoms. Patients with obstructive sleep apnoea syndrome should be screened for thyroid goitre.
Style APA, Harvard, Vancouver, ISO itp.
4

Toshniwal, Nandalal Girijalal, Shubhangi Amit Mani, Nilesh Mote i Ashwini Ramesh Nalkar. "Obstructive Sleep Apnoea in Orthodontics - A Review". Journal of Evolution of Medical and Dental Sciences 10, nr 35 (30.08.2021): 3040–46. http://dx.doi.org/10.14260/jemds/2021/620.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) is a sleep associated breathing disorder and it affects the health and quality of life of individuals suffering from it. Orthodontists should be well aware of the symptoms of this disorder and competent enough to recognize its signs and symptoms. Orthodontics is well suited for the treatment of OSA patients due to their expertise and knowledge regarding growth and development of orofacial and dentofacial structures as well as orthopaedic, orthodontic, and surgical correction of the jaws and other supporting tissues. There are basically two types of sleep apnoea- Central sleep apnoea and obstructive sleep apnoea where obstructive sleep apnoea is the more common one. This disorder can be life threatening as the oxygen supply to various parts of the body is substantially reduced. Obstructive sleep apnoea is caused by an interplay between a variety of factors, including sleep related loss of muscle tone in the tissues supplied by the glossopharyngeal nerve, anatomical obstruction of the nasal passages, large tonsils, large tongue, a retrognathic mandible, obesity, alcohol, sedative medication, and allergies. Sleep apnoea can be caused due to many factors and many treatment modalities have been employed to correct this disorder including mandibular advancement appliances, polysomnographs, and surgical intervention. It can be treated using surgery, continuous positive airway pressure and oral appliances therapy. This article highlights the role the orthodontist plays in the diagnosis and treatment planning of OSA patients. KEY WORDS Orthodontics, Obstructive Sleep Apnoea, Sleep, Snoring
Style APA, Harvard, Vancouver, ISO itp.
5

Timkova, Vladimira, Iveta Nagyova, Sijmen A. Reijneveld, Ruzena Tkacova, Roy E. Stewart, Jitse P. van Dijk i Ute Bültmann. "Suicidal ideation in patients with obstructive sleep apnoea and its relationship with disease severity, sleep-related problems and social support". Journal of Health Psychology 25, nr 10-11 (1.03.2018): 1450–61. http://dx.doi.org/10.1177/1359105318758859.

Pełny tekst źródła
Streszczenie:
We aimed to assess the prevalence of suicidal ideation and to examine the relationships between obstructive sleep apnoea severity, sleep-related problems, social support and suicidal ideation in obstructive sleep apnoea patients. We included 149 patients (68% male; mean age, 48.99 ± 9.57 years) with diagnosed obstructive sleep apnoea (Apnoea–Hypopnoea Index ⩾5) based on full-night polysomnography. The prevalence of suicidal ideation among obstructive sleep apnoea patients was 20.1 per cent. Structural equation modelling showed that suicidal ideation in obstructive sleep apnoea was strongly related to poor sleep quality and high fatigue levels. No relationship between social support and suicidal ideation in obstructive sleep apnoea patients was found.
Style APA, Harvard, Vancouver, ISO itp.
6

Casey, Deborah. "Obstructive sleep Apnoea". Nursing Standard 4, nr 52 (19.09.1990): 25–27. http://dx.doi.org/10.7748/ns.4.52.25.s41.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Gallacher, Rose. "Obstructive sleep apnoea". Nursing Standard 22, nr 29 (26.03.2008): 47. http://dx.doi.org/10.7748/ns.22.29.47.s39.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Marshall, Tom. "Obstructive sleep apnoea". British Journal of General Practice 66, nr 645 (31.03.2016): 178.3–179. http://dx.doi.org/10.3399/bjgp16x684493.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

TIERNEY, N. M., B. J. POLLARD i B. R. H. DORAN. "Obstructive sleep apnoea". Anaesthesia 44, nr 3 (marzec 1989): 235–37. http://dx.doi.org/10.1111/j.1365-2044.1989.tb11232.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

McNamara, S. G., R. R. Grunstein i C. E. Sullivan. "Obstructive sleep apnoea." Thorax 48, nr 7 (1.07.1993): 754–64. http://dx.doi.org/10.1136/thx.48.7.754.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Obstructive sleep apnoea"

1

Gunaratnam, Kogulan. "OBSTRUCTIVE SLEEP APNOEA AND PERIODONTITIS". Thesis, Faculty of Dentistry, 2008. http://hdl.handle.net/2123/4057.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) and its associated daytime symptoms form a syndrome, obstructive sleep apnoea-hypopnoea syndrome (OSAHS) that affects about 5% of the population worldwide (Young et al 2002a, Pack 2006). OSA is characterized by repeated episodes of upper airway obstruction during sleep, resulting in recurrent hypoxemia and sleep fragmentation (Hensley & Ray 2005). These in turn are associated with neurocognitive disorders, hypertension and cardiovascular complications (Pack 2006). Current therapies for this condition include surgical interventions, oral appliances and continuous positive airways pressure (CPAP). Systemic and local airway inflammation has recently been linked to OSA and is hypothesized to increase the risk of cardiovascular complications (Lavie 2005). While the exact mechanism is not certain, it is believed that the underlying systemic inflammation from OSA is due to the hypoxia/reperfusion injury from intermittent hypoxia that occurs with OSA (Lavie 2005). Specifically, the episodic hypoxia in OSA leads to increased production of reactive oxidative species (ROS) and, via various pathways, in the formation of systemic inflammatory mediators. The resultant inflammatory response is then responsible for the increased cardiovascular morbidity and mortality by potentiating disease in those that already have inflammatory disease or triggering inflammatory diseases in people with existing genetic, behavioural and environmental exposure. Periodontitis involves the supporting structures of the tooth and is a disease caused by specific bacteria that triggers an inflammatory response (Kinane 2001). Tissue damage and destruction, including loss of the connective tissue attachment between the tooth and the jaw, together with resorption of supporting bone, is initiated by the micro-organisms and mediated by the host response. Periodontitis, which is a severe form of periodontal disease, is one of the most common chronic infections in the world. The prevalence of moderate to severe periodontitis across the globe is in the range of 5 to 20 % (Burt 2005). Recent studies have speculated on an association between periodontitis and systemic inflammation in, for example, diabetes (Soskolne & Klinger 2001), rheumatoid arthritis (Mercado et al. 2000) and cardiovascular disease (CVD) (Beck & Offenbacher 2005), but no research has been undertaken on the link between OSA and periodontitis. This review will focus on features of OSA, inflammation and periodontitis to examine if there is a possible link between OSA and periodontitis by means of systemic inflammation.
Style APA, Harvard, Vancouver, ISO itp.
2

Mason, Rebecca Helen. "Vascular complications of obstructive sleep apnoea". Thesis, University of Bristol, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619138.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) is the third commonest respiratory condition after Asthma and COPD and has been increasingly linked to cardiovascular consequences. This thesis examines how OSA might affect different vascular beds; large (the aorta), medium (the carotid artery) and small (retinal and cerebral blood vessels) through five different studies. Each study will be reported as a separate chapter and a final discussion will assess the overall conclusions. Methodology Study one examines the prevalence of OSA in individuals with an abdominal aortic aneurysm and demonstrates the increased prevalence and rate of aneurysm expansion in those with severe OSA. Study two demonstrates the increased prevalence of OSA in individuals with type two diabetes and clinically significant diabetic macular oedema (CS MO). Study three examines the clinical benefit of continuous positive airway pressure (CPAP) in individuals with OSA and CS MO and demonstrates an improvement in visual acuity when CPAP is used for >2.5hrs per night. Study four is a retrospective examination of the effect of snoring on carotid vessel disease and shows no significant difference between the severity of snoring and degree of carotid artery stenosis. Study five describes the effect of minimally symptomatic obstructive sleep apnoea on cerebrovascular disease and shows no association between OSA and small white matter change but, does confirm the association of increasing age and hypertension. Discussion This thesis adds to our understanding of the association of OSA and vascular disease and the potential therapeutic benefits of CPAP in these individuals.
Style APA, Harvard, Vancouver, ISO itp.
3

Papaioannou, Ioannis. "Glucose intolerance in obstructive sleep apnoea". Thesis, Imperial College London, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516557.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Davies, David Paul. "Snoring, obstructive sleep apnoea and stroke". Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.364858.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

McMillan, Alison. "Obstructive sleep apnoea in older people". Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/28969.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) is common and the prevalence increases with age. When OSA leads to sleep disruption and excessive daytime sleepiness, it is referred to as obstructive sleep apnoea syndrome (OSAS). The aim of this thesis was to investigate the consequences of OSAS in older people (˃ 65 years) and the effect of continuous positive airway pressure (CPAP) therapy. CPAP is the treatment of choice in moderate to severe OSAS in middle aged people. However, there is a paucity of evidence on the therapeutic and economic benefits of CPAP in older people with OSAS. The two studies in this thesis aimed to address this by comparing outcomes in older people with OSAS before and after treatment with CPAP. The first study presented is the thesis is the PREDICT trial; a multicentre randomised controlled trial of CPAP in older people with OSAS. The trial studied the clinical efficacy of CPAP after 3 months, while determining the cost effectiveness of treatment over 12 months. The results of the trial showed that CPAP was an effective treatment for reducing excessive daytime sleepiness by -2.1 (95%CI -3.0 to -1.3); p < 0.001 points as measured by the Epworth sleepiness scale. CPAP also improved quality of life, with a statistically significant increase in the quality adjusted life years calculated with the SF-6D, equating to one week. The CPAP group also accrued marginally lower health care costs over 12 months compared to the group treated with best supportive care alone. Overall the economic benefit of CPAP was linked to the reduced healthcare usage offsetting the cost of the equipment. The second study presented in the thesis was a single centre randomised controlled trial to investigate the impact of CPAP on cognitive function and brain morphology in older people with minimally symptomatic OSAS after 6 months of treatment. In this study I tested the hypothesis that older patients with OSAS have cognitive impairment and corresponding brain changes which would be modifiable with treatment. The results of this study suggested older people with minimally symptomatic OSAS had normal cognitive function but impaired attention and executive function. CPAP treatment improved one aspect of attention, although memory and overall cognitive function were unchanged. The results of the brain MRI scans are not presented, and are in the process of being analysed. In conclusion the data presented in this thesis support the use of CPAP therapy in older people with excessive daytime sleepiness due to OSAS.
Style APA, Harvard, Vancouver, ISO itp.
6

Turino, Cecilia. "A new approach to obstructive sleep apnoea management". Doctoral thesis, Universitat de Lleida, 2021. http://hdl.handle.net/10803/673267.

Pełny tekst źródła
Streszczenie:
L'aplicació de la pressió positiva contínua en la via aèria superior (CPAP) representa el mètode terapèutic de referència de la Síndrome d'Apnea Obstructiva del Son (SAOS). No obstant això, la SAOS es considera una malaltia amb múltiples fenotips i resposta al tractament variable. Per tant, el tractament amb CPAP hauria d'aconsellar-se segons el fenotip dels pacients. Així doncs, es necessiten noves estratègies per millorar el compliment del mateix tractament. En el primer article hem identificat algunes variables relacionades amb la SAOS . En el segon article hem definit el perfil general dels pacients de Catalunya tractats amb CPAP i hem identificat sis clústers de pacients amb diferents patrons de comorbiditats, mortalitat i ús dels recursos sanitaris. En el tercer article la telemedicina va demostrar més cost efectivitat que el maneig tradicional del tractament amb CPAP. En el quart article, el Sistema Intel•ligent de Monitoratge (MiSAOS) va demostrar més cost efectiu que el maneig tradicional del tractament amb CPAP.
La aplicación de la presión positiva continua en la vía aérea superior (CPAP) representa el método terapéutico de referencia del Síndrome de Apneas Obstructivas del Sueño (SAOS) . Sin embargo, el SAOS se considera una enfermedad con múltiples fenotipos, por lo tanto, el tratamiento con CPAP debería aconsejarse según el fenotipo de los pacientes. Por otro lado, también se necesita nuevas estrategias para mejorar el cumplimento del mismo tratamiento. En el primer artículo hemos identificado algunas variables relacionadas con el SAOS . En el segundo artículo hemos definido el perfil general de los pacientes SAOS de Cataluña tratados con CPAP y hemos identificado seis clústers de pacientes con diferentes patrones de comorbilidades, mortalidad y uso de los recursos sanitarios. En el tercer artículo la telemonitorización demostró más coste efectividad que el manejo tradicional del tratamiento con CPAP. En el cuarto artículo, el Sistema Inteligente de Monitorización (MiSAOS) del cumplimiento con CPAP se demostró más coste efectivo que el manejo tradicional.
The application of continuous positive pressure (CPAP) represents the first line treatment for patients with Obstructive Sleep Apnoea (OSA) . However, OSA is now regarded as a disorder characterized by multiple phenotypes with variable response to treatment. Thus, CPAP treatment should be recommended according to phenotypes. On the other hand, new methods for improving CPAP compliance are required. In the first article we found some variables associated with OSA . In the second article, we defined a general profile of the entire CPAP-treated OSA population of Catalonia and identified six patient groups characterized by different patterns of comorbidities, mortality, and healthcare resource use. In the third article telemedicine did not improve CPAP compliance but was more cost effective than traditional follow-up. Finally, in the fourth article, the MiSAOS Intelligent Monitoring System for improving CPAP compliance resulted more cost effective than traditional management.
Style APA, Harvard, Vancouver, ISO itp.
7

West, Sophie Diana. "Obstructive sleep apnoea and type 2 diabetes". Thesis, University of Leicester, 2007. http://hdl.handle.net/2381/29539.

Pełny tekst źródła
Streszczenie:
Aims: To establish the prevalence of OSA in individuals with type 2 diabetes, and whether treatment with CPAP improves glycaemic control and insulin resistance. Methods and Results: A questionnaire was sent to 1682 men with type 2 diabetes from hospital and primary care databases. Fifty-six percent replied; 57% scored as 'high' and 39% as 'low' risk for OSA; 4% had known OSA. Overnight oximetry in 240 respondents from the 'high' and 'low' risk groups showed 31% and 13% respectively had significant OSA, verified by sleep studies. Exploration and oximetry data to the questionnaire respondent population suggests 23% have OSA. Comparison with a general population showed OSA prevalence to be significantly higher in the diabetes population (p<0.001). Multiple linear regression revealed diabetes was a significant independent OSA predictor after correction for BMI, explaining 8% of OSA variance (p<0.001). There was no correlation of OSA with HbA1c. A double blind randomized controlled trial of CPAP in men with type 2 diabetes and newly diagnosed OSA was performed. Forty-two men attended for baseline investigations and then received either therapeutic or placebo CPAP for 3 months; baseline tests were then repeated. In the therapeutic group, significantly improved subjective and objective sleepiness were noted, however no significant improvement in HbA1c, euglycaemic clamp, adiponectin or HOMA-%S were found. Conclusions: OSA is highly prevalent in men with type 2 diabetes; most individuals are undiagnosed. Diabetes may be a significant independent contributor to OSA risk. CPAP treatment of OSA does not improve insulin resistance or HbA1c in men with type 2 diabetes.
Style APA, Harvard, Vancouver, ISO itp.
8

Filtness, Ashleigh J. "Obstructive sleep apnoea and daytime driver sleepiness". Thesis, Loughborough University, 2011. https://dspace.lboro.ac.uk/2134/8338.

Pełny tekst źródła
Streszczenie:
Driver sleepiness is known to be a major contributor to road traffic incidents (RTIs). An initial literature review identified many studies reporting untreated obstructive sleep apnoea (OSA) sufferers as having impaired driving performance and increased RTI risk. It is consistently reported that treatment with continuous positive air pressure (CPAP) improves driving performance and decreases RTI risk, although most of these studies are conducted less than one year after starting treatment. UK law allows treated OSA patients to continue driving if their doctor states that treatment has been successful. Despite the wealth of publications surrounding OSA and driving, 6 key areas were identified from the literature review as not fully investigated, the: (i) prevalence of undiagnosed OSA in heavy goods vehicle (HGV) drivers in the UK; (ii) impact of sleep restriction on long term CPAP treated OSA compared with healthy controls; (iii) ability of treated OSA participants to identify sleepiness when driving; (iv) impact of one night CPAP withdrawal on driving performance; (v) individual difference in driving performance of long term CPAP treated OSA participants; (vi) choice of countermeasures to driver sleepiness by two groups susceptible to driver sleepiness, OSA and HGV drivers. Key areas (i) and (vi) were assessed using questionnaires. 148 HGV drivers were surveyed to assess OSA symptoms and preference of countermeasures to driver sleepiness. All participants completing the driving simulator study were also surveyed. 9.5% of HGV drivers were found to have symptoms of suspected undiagnosed OSA. Additionally the OSA risk factors were more prevalent for HGV drivers than reported in national statistics reports for the general population. The most effective countermeasures to driver sleepiness (caffeine and a nap) were not the most popular. Being part of a susceptible group (OSA or HGV driver) and prior experience of driver sleepiness did not promote effective choice of countermeasure. Key areas (ii) to (v) were assessed using a driving simulator. Driving simulators present a safe environment to test participants in a scenario where they may experience sleepiness without endangering other road users.
Style APA, Harvard, Vancouver, ISO itp.
9

Coughlin, Steven Robert. "The cardiovascular consequences of obstructive sleep apnoea". Thesis, University of Liverpool, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403099.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) is associated with increased cardiovascular morbidity and mortality, possibly because it clusters with a number of cardiovascular risk factors that comprise and underpin the metabolic syndrome. These include, obesity, high blood pressure, insulin resistance, impaired glucose tolerance and dyslipidaemia, and an increased sympathetic activity, altered cardiac autonomic tone and reduced baroreceptor sensitivity. However, it is currently unclear whether OSA clusters with these risk factors independently of obesity as studies investigating these relationships generally used BMI as a surrogate marker of adiposity. Likewise, a lack of intervention studies for the majority of these risk factors makes it difficult to assess whether OSA directly influences their development. The first aim of this thesis was to determine whether OSA was associated with the cardiovascular risk factors that comprise the metabolic syndrome independently of obesity. This was accomplished by measuring these cardiovascular risk factors in two groups of subjects with and without OSA whom were closely matched for a range of obesity related variables. The second aim of this thesis was to determine whether these risk factors resolved with the application of nasal continuous positive airways pressure (CPAP) treatment. This was investigated by randomising subjects to either CPAP or a sub-therapeutic alternative for a six week period and then crossed-over to the alternative treatment for a further six weeks. The cardiovascular risk factors were compared following CPAP and sub-therapeutic therapy. The methodologies used to measure these cardiovascular risk factors included; blood pressure measurements, a HOMA analysis of fasting glucose and insulin values to estimate insulin resistance, a full lipid profile, a urine catecholamine analysis, and spectral analyses of baroreceptor sensitivity and heart rate variability, the latter being an indirect measure of cardiac autonomic tone. The results of these studies demonstrated that whilst OSA was independently associated with a reduced HDL cholesterol, an increased incidence of the metabolic syndrome and values of cardiac autonomic tone that have previously been demonstrated to confer an increased cardiovascular risk following myocardial infarction, only systolic, diastolic and mean arterial blood pressures were significantly reduced by CPAP. Whilst the associations of OSA with these known cardiovascular risk factors may help explain the increased cardiovascular morbidity and mortality associated with this condition, the results of the intervention study suggest that OSA clusters with the majority of these risk factors because of a common cause rather than any direct effect. Whether this common cause is a shared genetic mechanism or because subjects with OSA exhibit a sedentary lifestyle, a known risk factor for the metabolic syndrome which develops as a consequence of their daytime sleepiness, remains unclear. Further intervention using a structured physical activity programme in subjects with OSA is needed to clarify this.
Style APA, Harvard, Vancouver, ISO itp.
10

Melehan, Kerri Louise. "Obstructive sleep apnoea and sexual function in men". Thesis, The University of Sydney, 2014. http://hdl.handle.net/2123/11857.

Pełny tekst źródła
Streszczenie:
Obstructive sleep apnoea (OSA) is associated with sexual dysfunction. Untreated OSA and erectile dysfunction (ED) have both been identified as being indicative of a high risk of developing cardiovascular disease. Treatments for ED, such as testosterone supplementation or PDE-5 inhibitors, and for OSA, such as Continuous Positive Airways Pressure (CPAP) are both readily available. The effects of these treatments on the other associated conditions have not been fully assessed. The efficacy of testosterone supplementation, in untreated OSA, on sexual function and quality of life has not been investigated. PDE-5 inhibitors are an established treatment for erectile dysfunction, however, there is a paucity of information regarding their efficacy in OSA, and there is a theoretical risk of worsening of OSA with their use. CPAP, in some observational and non-treatment or alternative treatment controlled studies, has been shown to improve erection function in men with OSA, however the majority of these studies have been in men with OSA, with and without ED. Two randomised controlled trials investigating the effects of testosterone in untreated OSA (n=67), and the effects of CPAP and a PDE-5 inhibitor in men with OSA and ED using a factorial design (n=61) were performed. Sleep, sexual function and quality of life was assessed. CPAP increased the quantity of nocturnal erections and a PDE-5 inhibitor improved their quality. However, neither CPAP use, exogenous testosterone nor a PDE-5 inhibitor improved subjective erectile function in men with OSA. Post-hoc analysis showed that adherent CPAP use (>4hours per night) increased subjective erectile function and sexual desire, as well as several parameters of quality of life in men with OSA and ED. Testosterone also increased sexual desire in men with OSA.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Obstructive sleep apnoea"

1

Fraser, Andrew K. Obstructive sleep apnoea and allied disorders. Glasgow: Scottish Forum for Public Health Medicine, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Rees, Karen. Mechanisms of arousal responses from NREM sleep in patients with obstructive sleep apnoea. Salford: University ofSalford, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Nicoll, Deborah J. Prospective evaluation of pulse transit time in the diagnosis and management of the obstructive sleep apnoea/hypopnoea syndrome. Oxford: Oxford Brookes University, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Carr, Michele M. Pediatric obstructive sleep apnea. Alexandria, VA: American Academy Of Otolaryngology--Head and Neck Surgery Foundation, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

name, No. Snoring and obstructive sleep apnea. Wyd. 3. Philadelphia, PA: Lippincott Willians & Wilkins, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Kim, Ki Beom, Reza Movahed, Raman K. Malhotra i Jeffrey J. Stanley, red. Management of Obstructive Sleep Apnea. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54146-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

de Vries, Nico, Madeline Ravesloot i J. Peter van Maanen, red. Positional Therapy in Obstructive Sleep Apnea. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-09626-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Salman, Salam O., red. Modern Management of Obstructive Sleep Apnea. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11443-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kim, Su-Jung, i Ki Beom Kim, red. Orthodontics in Obstructive Sleep Apnea Patients. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-24413-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Sacchetti, Lisandro M., i Priscilla Mangiardi. Obstructive sleep apnea: Causes, treatment and health implications. New York: Nova Science Publishers, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Obstructive sleep apnoea"

1

Clarke, R. W. "Obstructive Sleep Apnoea". W Pediatric ENT Radiology, 199–205. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-59367-3_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Goh, Daniel Y. T. "Obstructive Sleep Apnoea". W Paediatric Sleep Disorders, 67–77. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-5791-8_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jokic, Ruzica. "Obstructive Sleep Apnoea". W Sleep Disorders in Psychiatric Patients, 213–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-642-54836-9_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Clarke, Raymond W. "Obstructive Sleep Apnoea". W Diseases of the Ear, Nose & Throat in Children, 73–75. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9780429019128-16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Messiha, Ashraf, Ben Gurney i Piet Haers. "Obstructive Sleep Apnoea Syndrome". W Orthognathic Surgery, 690–700. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119004370.ch44.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Powell, Steven. "Paediatric Obstructive Sleep Apnoea". W Scott-Brown’s Otorhinolaryngology Head and Neck Surgery, 293–309. Eighth edition. | Boca Raton : CRC Press, [2018] | Preceded by Scott-Brown’s otorhinolaryngology, head and neck surgery.: CRC Press, 2018. http://dx.doi.org/10.1201/9780203731017-27.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

McNicholas, Walter T. "Obstructive Sleep Apnoea: Focus on Pathophysiology". W Advances in the Diagnosis and Treatment of Sleep Apnea, 31–42. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-06413-5_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Walijee, Hussein. "Adenotonsillar Conditions and Obstructive Sleep Apnoea". W Scott-Brown's Essential Otorhinolaryngology, 517–19. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003175995-103.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Krieger, J. "Obstructive sleep apnoea-hypopnea syndrome and upper airway resistance syndrome". W Sleep, 357–89. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0217-3_29.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Gill, Daljit S., i Farhad B. Naini. "The Multidisciplinary Management of Obstructive Sleep Apnoea". W Orthodontics: Principles and Practice, 263–69. West Sussex, UK: John Wiley & Sons, Ltd,., 2013. http://dx.doi.org/10.1002/9781118785041.ch27.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Obstructive sleep apnoea"

1

Neffati, O., H. Zaibi, B. Dhahri, J. Ben Ammar, M. A. Baccar, S. Azzabi i H. Aouina. "Obstructive sleep apnoea and hypothyroidism". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2366.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Baia Afonso, M. F., J. Carvalho, E. Nabais, M. Escaleira, R. Staats, P. Pinto i C. Bárbara. "Positional obstructive sleep apnoea – an individualized phenotype". W Sleep and Breathing 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2021.70.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Trakada, Georgia, Angeliki Konsta, Lemonia Velentza i Dimitris Dikeos. "Obstructive sleep apnoea and electroconvulsive therapy complications". W ERS/ESRS Sleep and Breathing Conference 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2017.p97.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Bouloukaki, Izolde, Athanasia Pataka, Paschalis Steiropoulos, Ludger Grote, Marisa Bonsignore, Jan Hedner, Oreste Marrone i in. "Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study". W ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4335.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Vukoja, Marija, Dragana Milicic, Aleksandar Bokan, Ilija Andrijevic i Ivan Kopitovic. "Lung function in patients with obstructive sleep apnoea". W ERS/ESRS Sleep and Breathing Conference 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2017.p14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Chaidas, K., i A. Ashman. "Funding for treatment of adult Obstructive Sleep Apnoea in England". W Sleep and Breathing 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2021.33.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Haqqee, Raana, Toni Jordan i Martin Allen. "Obstructive Sleep Apnoea (OSA): Men vs Women". W ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa2340.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Basnayake, Thilini, Amalia Karahalios, Lynette Reid-Price, David Bramley i Anne Marie Southcott. "Obstructive sleep apnoea and post-operative complications". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2407.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Shaikh, Zarrin, Mary J. Morrell, Michael I. Polkey i Michael Mullen. "Patent Foramen Ovale In Obstructive Sleep Apnoea". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a3683.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Lo Iacono, C. A. M., C. D'Alessandro, E. Amato i I. Carbone. "Sex differences in obstructive sleep apnoea in aging: a retrospective study". W Sleep and Breathing 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.sleepandbreathing-2021.10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Obstructive sleep apnoea"

1

Yu, Zhixiang, Qiuhe Ji, Fu Yi i Jinxiang Cheng. Association Between Obstructive Sleep Apnoea And T2DM: A Dose-Response Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2020. http://dx.doi.org/10.37766/inplasy2020.11.0027.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Torres, Claudia Fernandez, i Alvaro Zubizarreta Macho. Mandibular advancement appliances to treat apnea: an update of the most used currently. A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0034.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Mandibular advancement devices used to treat obstructive sleep apnea. Condition being studied: Obstructive sleep apnea is characterized by episodes of a complete (apnea) or partial collapse (hypopnea) of the upper airway with an associated decrease in oxygen saturation or arousal from sleep. This disturbance results in fragmented, nonrestorative sleep. Other symptoms include loud, disruptive snoring, witnessed apneas during sleep, and excessive daytime sleepiness. OSA has significant implications for cardiovascular health, mental illness, quality of life, and driving safety.
Style APA, Harvard, Vancouver, ISO itp.
3

Czerwaty, Katarzyna, Karolina Dżaman, Krystyna Maria Sobczyk i Katarzyna Irmina Sikrorska. The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2022. http://dx.doi.org/10.37766/inplasy2022.11.0077.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To provide the essential findings in the field of overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea, including prevalence, possible predictors, association with clinical outcomes, and severity compared to both chronic obstructive pulmonary disease and obstructive sleep apnea patients. Condition being studied: OSA is characterized by complete cessation (apnea) or significant decrease (hy-popnea) in airflow during sleep and recurrent episodes of upper airway collapse cause it during sleep leading to nocturnal oxyhemoglobin desaturations and arousals from rest. The recurrent arousals which occur in OSA lead to neurocognitive consequences, daytime sleepiness, and reduced quality of life. Because of apneas and hypopneas, patients are experiencing hypoxemia and hypercapnia, which result in increasing levels of catecholamine, oxidative stress, and low-grade inflammation that lead to the appearance of cardio-metabolic consequences of OSA. COPD is a chronic inflammatory lung disease defined by persistent, usually pro-gressive AFL (airflow limitation). Changes in lung mechanics lead to the main clini-cal manifestations of dyspnea, cough, and chronic expectoration. Furthermore, patients with COPD often suffer from anxiety and depression also, the risk of OSA and insomnia is higher than those hospitalized for other reasons. Although COPD is twice as rare as asthma but is the cause of death eight times more often.
Style APA, Harvard, Vancouver, ISO itp.
4

Torres-Castro, Rodrigo, Lilian Solis-Navarro, Homero Puppo, Roberto Vera-Uribe, Victoria Alcaraz-Serrano i Jordi Vilaró. Respiratory muscle training in patients with obstructive sleep apnea: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, luty 2022. http://dx.doi.org/10.37766/inplasy2022.2.0096.

Pełny tekst źródła
Streszczenie:
Review question / Objective: Is respiratory muscle training effective in patients with obstructive sleep apnea? Condition being studied: Effects of respiratory muscle training in patients with obstructive sleep apnea. Information sources: We included the following databases: Pubmed, CENTRAL, Web of Science, CINAHL, EMBASE, Scopus and Scielo. Additionally, the references list of the included studies will be manually reviewed.
Style APA, Harvard, Vancouver, ISO itp.
5

Hazboun, Tawfiq N. Obstructive Sleep Apnea Oral Appliance vs. Auto Titrating Positive Airway Pressure. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2013. http://dx.doi.org/10.21236/ad1012981.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Sun, Dong, Yanan Zhang i Di Zhou. The relationship between obstructive sleep apnea and retinal vein occlusion : a Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, luty 2022. http://dx.doi.org/10.37766/inplasy2022.2.0068.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Lu, Jiyuan, Lingdan Xu, Yanduo Yang, Yucheng Meng, Yi Li, Huihui Wang i Bin Liu. Obstructive sleep apnea and serum total testosterone: a system review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0110.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Parthasarathy, Sairam, Stefano Guerra, Stuart F. Quan, Michael Grandner i Patricia L. Haynes. Does a Peer Support Program Improve Satisfaction With Treatment Among Patients With Obstructive Sleep Apnea? Patient-Centered Outcomes Research Institute (PCORI), kwiecień 2020. http://dx.doi.org/10.25302/04.2020.ihs.130602505.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Zhang, Dong, Zhi Xiang Yu i Fu Yi. Atrial fibrillation And the Severe of Obstructive Sleep Apnea (OSA): A Dose-Response Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, grudzień 2020. http://dx.doi.org/10.37766/inplasy2020.12.0104.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zhuo, Guifeng, Hengwang Yu, Ran Liao, Xuexia Zheng, Dongmin Liu, Libing Mei i Guiling Wu. Electroacupuncture for Obstructive Sleep Apnea Hypoventilation Syndrome: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, kwiecień 2022. http://dx.doi.org/10.37766/inplasy2022.4.0090.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Obstructive sleep apnoea” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii